Care recommendations for patients with cancer and hematological neoplasms amid the COVID-19 pandemic in Colombia

Revista Colombiana de Cancerología

View Publication Info
 
 
Field Value
 
Title Care recommendations for patients with cancer and hematological neoplasms amid the COVID-19 pandemic in Colombia
Recomendaciones para el cuidado de pacientes con cáncer y neoplasias hematológicas en el estado de pandemia COVID-19 en Colombia
 
Creator Ospina-Serrano, Aylen Vanessa
abello-Polo, Virginia
Patino-Escobar, Bonell
Godoy-Barbosa, Javier Ignacio
Gonzalez, Jaime
Idrobo, Henry
Lopera-Cortés, Diego Emilio
Martinez-Cordero, Humberto
Quintero-Ocaris, Mario Fernando
Segovia-Gomez, Javier
Vargas-Baez, Carlos Alberto
Yepes, Andres
 
Subject COVID-19
Oncology
Hematology
Care
Pandemic
COVID-19
Oncología
Hematología
Cuidados
Pandemia
 
Description IIn response to the Covid-19 pandemic, declared in March 2020 by the World Health Organization (WHO), the Colombian Association of Hematology and Oncology (ACHO) has been issuing communications aimed at providing guidance to health professionals involved in the treatment of hematological and oncological patients. Considering the pandemic mitigation phase we are currently facing, and the government’s approach to progressively tapering-off the quarantine, we deem it important to release a new update. These recommendations are not intended to impose a single conduct, since we understand that each case has particular characteristics and therefore it must be acted upon by individualizing each specific situation. The recommendations are based on documents issued by well-known cancer and hematological scientific associations, and are subject to change as  more information becomes available.
Ante la pandemia COVID 19, declarada en marzo de 2020 por la Organización Mundial de la Salud (OMS), desde la Asociación Colombiana de Hematología y Oncología (ACHO) hemos venido emitiendo comunicaciones destinadas a orientar a los profesionales de la salud implicados en el tratamiento de pacientes hematológicos y oncológicos. Consideramos importante realizar una nueva actualización dada la fase de mitigación de la pandemia que actualmente estamos enfrentando y ante el planteamiento gubernamental de desdescalonamiento progresivo, de la cuarentena.Estas recomendaciones no pretenden imponer una conducta única pues entendemos que cada caso es particular y debe actuarse individualizando a cada situación específica. Están basadas en documentos emitidos por asociaciones científicas oncológicas y hematológicas reconocidas y son susceptibles de sufrir modificaciones a medida que se disponga de mayor información.
 
 
Publisher Instituto Nacional de Cancerología
 
Date 2020-11-30
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
 
Format application/pdf
 
Identifier https://www.revistacancercol.org/index.php/cancer/article/view/701
10.35509/01239015.701
 
Source Revista Colombiana de Cancerología; Vol. 24 (2020): Suplemento 1
Revista Colombiana de Cancerología; Vol. 24 (2020): Suplemento 1
Revista Colombiana de Cancerología; v. 24 (2020): Suplemento 1
2346-0199
0123-9015
 
Language spa
 
Relation https://www.revistacancercol.org/index.php/cancer/article/view/701/518
/*ref*/Salud INd. Coronavirus (COVID-19) en Colombia https://www.ins.gov.co/Noticias/Paginas/Coronavirus.aspx: Instituto Nacional de Salud; 2020. 2. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335-7. https://doi.org/10.1016/S1470-2045(20)30096-6 3. Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31(7):894-901. https://doi.org/10.1016/j.annonc.2020.03.296 4. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5 5. ASCO. ASCO Special Report: A guide to cancer care delivery during the COVID-19 PANDEMIC. May 19, 20202020. 6. ESMO. ESMO Recommendiations: Cancer patient managment during COVID-19 pandemic. General Introduction. Slides sets [Internet]. 2020. 7. SEOM. Posicionamiento-Recomendaciones SEOM sobre el cribado serológico previo al inicio de una quimioterapia inmunosupresora durante la pandemia COVID19. Pacientes asintomáticos sin infección conocida. https://seom.org/images/Posicionamiento_TESTS_COVID_QUIMIO.pdf: SEOM 2020. 8. Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395(10241):1907-18. https://doi.org/10.1016/S0140-6736(20)31187-99. AMA. AMA quick guide to telemedicine in practice: https://www.ama-assn.org/practice-management/digital/ama-quickguide-telemedicine-practice; 2020. 10. Saavedra C. Consenso Colombiano de atención, diagnóstico y manejo de infección por SAR-COV-2/COVID-19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio. 2020;24(3). https://doi.org/10.22354/in.v24i3.852 11. Ueda M, Martins R, Hendrie PC, McDonnell T, Crews JR, Wong TL, et al. Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal. J Natl Compr Canc Netw. 2020:1-4. https://doi.org/10.6004/jnccn.2020.7560 12. Hunter E, Price DA, Murphy E, van der Loeff IS, Baker KF, Lendrem D, et al. First experience of COVID-19 screening of health-care workers in England. Lancet. 2020;395(10234):e77-e8. https://doi.org/10.1016/S0140-6736(20)30970-3 13. Quattrone F, Vabanesi M, Borghini A, De Vito G, Emdin M, Passino C. The value of hospital personnel serological screening in an integrated COVID-19 infection prevention and control strategy. Infect Control Hosp Epidemiol. 2020:1-2. https://doi.org/10.1017/ice.2020.242 14. Hanna TP, Evans GA, Booth CM. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic. Nat Rev Clin Oncol. 2020;17(5):268-70. https://doi.org/10.1038/s41571-020-0362-6 15. ASCO SPECIAL REPORT: A GUIDE TO CANCER CARE DELIVERY DURING THE COVID-19 PANDEMIC. MAY 19, 2020. 16. ESMO Recommendiations: Cancer patient managment duringCOVID-19 pandemic. General Introduction. Slides sets [Internet]. 2020. 17. Wang Y, Zhang S, Wei L, Lin Z, Wang X, Wang J, et al.Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists. J Gynecol Oncol. 2020;31(4):e68. https://doi.org/10.3802/jgo.2020.31.e68 18. Kimberly H, Angela C, Arias C, Englund J, Lee M. Infectious Diseases Society of America G8uidelines on the Diagnosis of COVID-192020. 19. Solodky ML, Galvez C, Russias B, Detourbet P, N’Guyen-Bonin V, Herr AL, et al. Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19. Ann Oncol. 2020; 31(8):1087-8. https://doi.org/10.1016/j.annonc.2020.04.475 20. Saavedra C. Adendo: Actualización Consenso 27/06/2020. Consenso Colombiano de atención, diagnóstico y manejo de la infección por SARS-CoV-2/COVID-19 en establecimientos de atención de la salud. Segunda edición. Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio. 2020;24(3). https://doi.org/10.22354/in.v24i3.895 21. AEC, editor. Qué debemos saber los cirujanos en los casos de patología oncológica en el contexto de la pandemia por covid-19 (SARS-CoV-2)? recomendaciones del grupo “Cirugia AEC-COVID19” de la Asociación española de cirujanos (AEC), versión actualizada 30 marzo2020. Disponible en: https://www.aecirujanos.es/files/noticias/152/documentos/dossier_v_1_10.pdf:Asociación Española de Cirujanos; 2020. 22. AEC. Recomendaciones de actuación en cirugía oncológica del área hepatobiliopancreática durante la pandemia COVID-192020. 23. AEC. Recomendaciones de actuación en cirugía oncológica esófago-gástricas durante la pandemia COVID-19 (V3, 2-42020)2020. 24. Younes N, Al-Sadeq DW, Al-Jighefee H, Younes S, Al-Jamal O, Daas HI, et al. Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2. Viruses. 2020;12(6):582. https://doi.org/10.3390/v12060582 25. Di Saverio S, Pata F, Gallo G, Carrano F, Scorza A, Sileri P, et al. Coronavirus pandemic and colorectal surgery: practical advice based on the Italian experience. Colorectal Dis. 2020;22(6):62534. https://doi.org/10.1111/codi.15056 26. The Royal College of Surgeons of England. COVID-19: Good Practice for Surgeons and Surgical Teams [internet]; 2020. Disponible en: https://www.rcseng.ac.uk/standards-and-research/standardsand-guidance/good-practice-guides/coronavirus/covid-19-goodpractice-for-surgeons-and-surgical-teams/ 27. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. https://doi.org/10.1016/S01406736(20)30211-7 28. von Lilienfeld-Toal M, Vehreschild JJ, Cornely O, Pagano L, Compagno F, Hirsch HH, et al. Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases. Leukemia. 2020;34(6):1487-94. https://doi.org/10.1038/s41375-020-0832-y 29. EBMT. Coronavirus Disease EBMT Recommendations.2020; VERSION 8 - MAY 18, 2020. 30. Willan J, King A, Hayes S, Collins G, Peniket A. Care of haematology patients in a COVID-19 epidemic. Br J Hematol. 2020; 189(2):241-3. https://doi.org/10.1111/bjh.16620 31. Indini A, Aschele C, Cavanna L, Clerico M, Daniele B, Fiorentini G, et al. Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey. Eur J Cancer. 2020;132:17-23. https://doi.org/10.1016/j.ejca.2020.03.024 32. Gavillet M, Carr Klappert J, Spertini O, Blum S. Acute leukemia in the time of COVID-19. Leuk Res. 2020;92:106353. https://doi.org/10.1016/j.leukres.2020.106353 33. SEEH. Actuación frente a COVID-19 en Receptores de Trasplante de Progenitores Hematopoyéticos y pacientes Oncohematológicos. Versión 5. Abril 22 20202020. 34. ASH. COVID-19 and Acute Myeloid Leukemia: Frequently Asked Questions; 2020. 35. GELTAMO. Recomendaciones del Comité Científico del grupo GELTAMO para el manejo de los pacientes con linfoma durante la crisis del Covid-19 [internet]. Versión 1 (19 marzo 2020). Disponible en: https://www.sehh.es/covid-19/recomendaciones/123783-recomendaciones-del-comitecientifico-del-grupo-geltamo-para-el-manejo-de-los-pacientescon-linfoma-durante-la-crisis-del-covid-192020. 36. Martinez-Codero H, Martínez LM, Ospina JA, Ruiz Argüelles G, Abello Polo V. Consenso del Grupo Latinoamericano de estudio de Mieloma Múltiple (MM) GELAMM para el manejo del MM en estado de Pandemia SARS CoV-2 / COVID 19 Recomendaciones Basadas en Consenso de Expertos. Rev Colomb Cancerol. 2020;22(24). 37. Ospina JA, Martínez-Cordero H, Idrobo QH. CONSENSO Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL) para el manejo del linfoma en estado de pandemia SARS CoV-2 / COVID 19. Rev Colomb Cancerol. 2020;22(24). 38. ASH. COVID-19 and Indolent Lymphomas: Frequently Asked Questions; 2020. 39. ASTCT. Interim Guidelines for COVID-19 management in Hematopoietic Cell Transplantation and Cellular Therapy Patients [internet]. Version 1.3. April 16, 2020. Disponible en: https://higherlogicdownload.s3.amazonaws.com/ASBMT/a1e2ac9a-36d2-4e23-945c-45118b667268/UploadedImages/COVID-19_Interim_Patient_Guidelines_4_20_20.pdf2020.
 
Rights Derechos de autor 2020 Revista Colombiana de Cancerología
 

Contact Us

The PKP Index is an initiative of the Public Knowledge Project.

For PKP Publishing Services please use the PKP|PS contact form.

For support with PKP software we encourage users to consult our wiki for documentation and search our support forums.

For any other correspondence feel free to contact us using the PKP contact form.

Find Us

Twitter

Copyright © 2015-2018 Simon Fraser University Library